Literature DB >> 36108149

Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses.

Ernesto Gargiulo1, Elodie Viry1, Pablo Elias Morande1, Anne Largeot1, Susanne Gonder1, Feng Xian1, Nikolaos Ioannou2, Mohaned Benzarti1, Felix Bruno Kleine Borgmann1, Michel Mittelbronn1, Gunnar Dittmar3, Petr V Nazarov4, Johannes Meiser1, Basile Stamatopoulos5, Alan G Ramsay6, Etienne Moussay1, Jerome Paggetti1.   

Abstract

Small extracellular vesicles (sEV, or exosomes) communication among cells in the tumor microenvironment has been modeled mainly in cell culture, while their relevance in cancer pathogenesis and progression in vivo is less characterized. Here we investigated cancer-microenvironment interactions in vivo using mouse models of chronic lymphocytic leukemia (CLL). sEV isolated directly from CLL tissue were enriched in specific miRNA and immune checkpoint ligands. Distinct molecular components of tumor-derived sEV altered CD8+ T-cell transcriptome, proteome and metabolome leading to decreased functions and cell exhaustion ex vivo and in vivo. Using antagomiRs and blocking antibodies, we defined specific cargo-mediated alterations on CD8+ T-cells. Abrogating sEV biogenesis by Rab27a/b knockout dramatically delayed CLL pathogenesis. This phenotype was rescued by exogenous leukemic sEV or CD8+ T-cell depletion. Finally, high expression of sEV-related genes correlated with poor outcomes in CLL patients, suggesting sEV profiling as prognostic tool. In conclusion, sEV shape the immune microenvironment during CLL progression.

Entities:  

Year:  2022        PMID: 36108149     DOI: 10.1158/2643-3230.BCD-22-0029

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN: 2643-3230


  1 in total

1.  Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo.

Authors:  Ernesto Gargiulo; Elodie Viry; Etienne Moussay; Jerome Paggetti
Journal:  Oncoimmunology       Date:  2022-09-27       Impact factor: 7.723

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.